2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

• Published in: Journal of the American College of Cardiology Vol. 64; no. 18; pp. 1929 - 1949
• Main Authors: Fihn, Stephan D., MD, MPH, Blankenship, James C., MD, MHCM, MACC, FAHA, Alexander, Karen P., MD, FACC, FAHA, Bittl, John A., MD, FACC, Byrne, John G., MD, FACC, Fletcher, Barbara J., RN, MN, FAHA, Fonarow, Gregg C., MD, FACC, FAHA, Lange, Richard A., MD, FACC, FAHA, Levine, Glenn N., MD, FACC, FAHA, Maddox, Thomas M., MD, MSc, FACC, FAHA, Naidu, Srihari S., MD, FACC, FAHA, FSCAI, Ohman, E. Magnus, MD, FACC, Smith, Peter K., MD, FACC
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 04-11-2014; Elsevier; Elsevier Limited
• Subjects: ACC/AHA Clinical Practice Guidelines; Biological and medical sciences; cardiac catheterization; Cardiology; Cardiology. Vascular system; Cardiovascular; Cardiovascular disease; chelation therapy; coronary angiography; coronary artery bypass graft; Coronary heart disease; counterpulsation; diagnostic techniques; focused update; Heart; Internal Medicine; Medical imaging; Medical sciences; myocardial ischemia; Myocarditis. Cardiomyopathies; Patients; percutaneous coronary intervention; Physicians; Studies; Surgery; Task forces; Thoracic surgery; Writing; ACC/AHA Clinical Practice Guidelines; percutaneous coronary intervention; counterpulsation; cardiac catheterization; diagnostic techniques; chelation therapy; myocardial ischemia; coronary artery bypass graft; cardiovascular; focused update; coronary angiography; Human; Myocardial ischemia; Patient; Cardiovascular disease; Myocardial disease; Coronary heart disease; Recommendation; Vascular disease; Clinical management; Treatment; Circulatory system; Diagnosis; Cardiology; PCNA antigen
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2014.07.017

Because the ACC/AHA practice guidelines address patient populations (and healthcare providers) residing in North America, drugs that are currently unavailable in North America are discussed in the text without a specific COR. For studies performed in large numbers of subjects outside North America, a writing committee reviews the potential impact of different practice patterns and patient populations on the treatment effect and relevance to the ACC/AHA target population to determine whether the findings should inform a specific recommendation.\n Sabik Content Reviewer--ACC Surgeons' Scientific Council Cleveland Clinic--Department Chair, Thoracic and Cardiovascular Surgery Edwards Lifesciences Medtronic None Abbott Laboratories[dagger] Edwards Lifesciences[dagger] None Vikas Saini Content Reviewer The Lown Institute--President None None None None Frank W. Sellke Content Reviewer--ACC/AHA Task Force on Practice Guidelines Brown Medical School and Lifespan--Chief of Cardiothoracic Surgery None None The Medicines Company None William S. Weintraub Content Reviewer Christiana Care Health System--Section Chief, Cardiology Bristol-Myers Squibb Daiichi-Sankyo Eli Lilly None None None Christopher J. White Content Reviewer Ochsner Health System--Director, John Ochsner Heart and Vascular Institute None None None St. Jude Medical (DSMB) Sankey V. Williams Content Reviewer--ACP University of Pennsylvania Health System--Professor of General Medicine None None None None Poh Shuan Daniel Yeo Content Reviewer--AIG Tan Tock Seng Hospital, Department of Cardiology--Cardiologist None None None Boston Scientific[dagger] Merck[dagger] Schering-Plough[dagger] * No reviewer had a relevant ownership, partnership, or principal position to report.